David Baltimore

Director, Amgen.

Companies

Regulus Therapeutics Inc.Board member Oct 4, 2012 to now¹
AmgenBoard member Mar 17, 2006 to May 1, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Regulus Therapeutics Inc.0 shares³Jun 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 25, 2025Returned to company 57,292 shares of Regulus Therapeutics Inc.³
Jun 25, 2025U 5,208 shares of Regulus Therapeutics Inc.³
Jun 25, 2025Returned to company 57,292 shares of Regulus Therapeutics Inc.³
Jun 25, 2025U 27,377 shares of Regulus Therapeutics Inc.³
Apr 30, 2025Granted 62,500 shares of Regulus Therapeutics Inc.⁴
Apr 30, 2025Granted 62,500 shares of Regulus Therapeutics Inc.⁴
Jan 30, 2025Bought 19,610 shares at $1.06 of Regulus Therapeutics Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRegulus Therapeutics Inc., Board member
2
SEC EDGARAmgen, Board member
3
SEC EDGARRegulus Therapeutics Inc. shares after the filing of Jun 25, 2025
4
SEC EDGARForm 4 filed Apr 30, 2025
5
SEC EDGARForm 4 filed Jan 31, 2025